Intuitive Surgical (ISRG) Gets a Buy from BTIG
BTIG analyst Ryan Zimmerman maintained a Buy rating on Intuitive Surgical yesterday and set a price target of $616.00.
Easter Sale - 70% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to TipRanks, Zimmerman is an analyst with an average return of -0.4% and a 40.00% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Stryker, Alcon, and Hologic.
In addition to BTIG, Intuitive Surgical also received a Buy from Goldman Sachs’s David Roman in a report issued on April 9. However, on April 6, Evercore ISI maintained a Hold rating on Intuitive Surgical (NASDAQ: ISRG).
Based on Intuitive Surgical’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $2.87 billion and a net profit of $794.8 million. In comparison, last year the company earned a revenue of $2.41 billion and had a net profit of $685.7 million
Read More on ISRG:
Disclaimer & DisclosureReport an Issue
- Intuitive Surgical price target lowered to $480 from $550 at Evercore ISI
- Private Markets: Kraken pauses IPO plans, Quince raises $500M
- IHI, IHE, ARKG: Specialty Healthcare ETFs Offer Diversification and Growth to Investors
- Intuitive Surgical: Stapler Reload Recall Seen as Contained, Buy Rating Reaffirmed
- Intuitive Surgical recalls curved-tip surgical staplers, says FDA
